Technical Analysis for VNRX - VolitionRX Limited
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
180 Bearish Setup | Bearish Swing Setup | 0.00% | |
Earnings Movers | Other | 0.00% | |
BB Squeeze Ended | Range Expansion | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Bollinger Band Squeeze | Range Contraction | -9.15% | |
BB Squeeze + Lower Band Touch | Range Contraction | -9.15% | |
BB Squeeze Started | Range Contraction | -9.15% |
Alert | Time |
---|---|
Outside Day | about 19 hours ago |
Down 5% | about 19 hours ago |
Fell Below Lower Bollinger Band | about 19 hours ago |
Fell Below Previous Day's Low | about 19 hours ago |
Lower Bollinger Band Support | about 19 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 03/18/2024
VolitionRX Limited Description
VolitionRX Limited, a development stage life sciences company, focuses on developing cancer detection blood tests for detecting and diagnosing cancer and other diseases. It develops two blood tests in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer and nucleosomes containing specific histone variants. The company also develops nine blood tests in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones, the proteins that package, and order DNA into nucleosomes; and five blood tests in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts, as well as offers research kits. It develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help appropriate therapy; NuQ Endo endometriosis test; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Biology Disease Molecular Biology Genomics Diagnostic Products Blood Test Epigenetics Endometriosis Nucleotides
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.1 |
52 Week Low | 0.55 |
Average Volume | 104,354 |
200-Day Moving Average | 1.05 |
50-Day Moving Average | 1.01 |
20-Day Moving Average | 0.98 |
10-Day Moving Average | 0.96 |
Average True Range | 0.09 |
RSI (14) | 41.86 |
ADX | 13.58 |
+DI | 12.39 |
-DI | 19.46 |
Chandelier Exit (Long, 3 ATRs) | 0.85 |
Chandelier Exit (Short, 3 ATRs) | 1.12 |
Upper Bollinger Bands | 1.09 |
Lower Bollinger Band | 0.88 |
Percent B (%b) | -0.03 |
BandWidth | 21.01 |
MACD Line | -0.02 |
MACD Signal Line | -0.01 |
MACD Histogram | -0.0121 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.02 | ||||
Resistance 3 (R3) | 1.04 | 1.00 | 0.99 | ||
Resistance 2 (R2) | 1.00 | 0.97 | 0.99 | 0.99 | |
Resistance 1 (R1) | 0.94 | 0.94 | 0.92 | 0.92 | 0.98 |
Pivot Point | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 |
Support 1 (S1) | 0.84 | 0.87 | 0.82 | 0.82 | 0.77 |
Support 2 (S2) | 0.81 | 0.84 | 0.80 | 0.76 | |
Support 3 (S3) | 0.74 | 0.81 | 0.75 | ||
Support 4 (S4) | 0.73 |